Funder
ANSTO/Australian & New Zealand Society of Nuclear Medicine
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,Instrumentation,Biomedical Engineering,Radiation
Reference44 articles.
1. Ersahin D, Doddamane I, Cheng D. Targeted Radionuclide Therapy. Cancers (Basel). 2011; 3(4):3838–55. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763399/ .
2. Murthy R, Kamat P, Nuñez R, Salem R. Radioembolization of Yttrium-90 Microspheres for Hepatic Malignancy. Semin Intervent Radiol. 2008; 25(1):48–57. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036397/ .
3. Delpassand ES, Samarghandi A, Zamanian S, Wolin EM, Hamiditabar M, Espenan GD, et al.Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors: the first US phase 2 experience. Pancreas. 2014; 43(4):518–25.
4. Parker C, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fosså SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013; 369(3):213–23. Available from: http://doi.org/10.1056/NEJMoa1213755 .
5. Solanki J, Tritt T, Pasternack J, Kim J, Domogauer J, Colangelo N, et al.Cellular response to exponentially increasing and decreasing dose rates. J Nucl Med.2016;57(supplement 2). Available from: http://jnm.snmjournals.org/content/57/supplement_2/1354 .
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献